EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) saw a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 30,078 shares, a growth of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 19,800 shares, the days-to-cover ratio is presently 1.5 days.
EKF Diagnostics Stock Performance
Shares of EKDHF remained flat at $0.34 during mid-day trading on Monday. The company has a 50-day moving average of $0.34 and a two-hundred day moving average of $0.34. EKF Diagnostics has a 52 week low of $0.29 and a 52 week high of $0.42.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.
EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.
Featured Stories
- Five stocks we like better than EKF Diagnostics
- Insider Confidence Is Building in These 3 Very Different Stocks
- The SaaSpocalypse Trade Is Cracking, and These 5 Stocks Are Leading Higher
- Microsoft’s Split Verdict Tests Investing Without a Fed Safety Net
- Broadcom’s Earnings Test Comes With a Higher Bar After NVIDIA’s Blowout
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
